J. Scott Applewhite / AP

After a grueling session that lasted overnight and through the morning, the House Energy and Commerce Committee did what everyone knew it would do from the beginning: It approved its piece of the House Republican Obamacare replacement package on a party-line vote. The bill survived the marathon markup session basically unchanged, except for technical tweaks from the Republican side.

How it ended: Despite all of the bitter arguments about which was worse — Obamacare or the new bill — all of the anger seemed to be gone at the end, as dazed-looking Republicans and Democrats just wanted to get it over with. They all gave a round of applause to committee chairman Greg Walden and the committee staff members for making it through the night. Ranking Democrat Frank Pallone gave one last speech about how the GOP bill would "rip health care away from millions of Americans," but even his heart didn't really seem to be in it.

What's next: Rep. Joe Barton withdrew one important amendment he had expected to offer: ending Obamacare's Medicaid expansion at the end of this year rather than in 2020. That was a concession to conservatives, and has already been endorsed by groups like the Republican Study Committee. Barton said the White House is "looking at it" and that he has gotten a "considerable amount of positive feedback" in private conversations. So look for it to return later in the process.

Go deeper

The hard seltzer wars are heating up

Illustration: Aïda Amer/Axios

Competition in the hard seltzer market is heating up in the closing weeks of summer, as big companies like Constellation Brands, AB InBev and Molson Coors have entered the market and Coca-Cola is poised to join the fray in 2021.

Why it matters: The coronavirus pandemic has increased alcohol sales overall and hard seltzers are exploding in popularity and look to have staying power, boasting record high sales in recent weeks.

Why you should be skeptical of Russia's coronavirus vaccine claims

Photo: Alexey Druzhini/Sputnik/AFP via Getty Images

Russian President Vladimir Putin announced Tuesday that his country has registered a coronavirus vaccine and said that one of his daughters has already been inoculated, AP reports.

Why it matters: Scientists around the world are skeptical about Russia's claims. There is no published scientific data to back up Putin's claims that Russia has a viable vaccine — or that it produces any sort of immunity without significant side effects.

A quandary for state unemployment agencies

Illustration: Aïda Amer/Axios

State agencies charged with paying unemployment benefits to jobless residents have their backs against the wall as they rush to parse President Trump's executive actions on coronavirus aid.

Why it matters: States are being asked to pitch in $100 per unemployed resident, but it’s a heavy lift for cash-strapped states that are still unclear about the details and may not opt-in at all. It leaves the states and jobless residents in a state of limbo.